Several types of imaging scans can reveal cancer, each using a different method to make tumors visible. The right scan depends on the type of cancer suspected, where it might be located, and whether doctors are screening, diagnosing, or tracking treatment. Here’s how each one works and what it’s best at finding.
CT Scans: Detailed Cross-Sectional Images
CT scans (computed tomography) use X-rays taken from multiple angles to build detailed 3D pictures of the inside of your body. They’re one of the most versatile tools in cancer care, used for everything from initial detection to staging, biopsy guidance, and monitoring treatment response. Modern spiral CT scanners are fast and produce high-resolution images that can pick up small abnormalities in the lungs, liver, abdomen, and pelvis.
Low-dose CT is the standard screening tool for lung cancer in people at high risk, such as long-term smokers. A variation called CT colonography (virtual colonoscopy) can screen for large colorectal polyps and tumors without a traditional scope. CT is also the go-to scan for checking whether cancer has spread to lymph nodes or distant organs, because it covers large areas of the body quickly.
MRI: Best for Soft Tissue
MRI (magnetic resonance imaging) uses strong magnets and radio waves instead of radiation. It excels at imaging soft tissues that are harder to see on other scans, making it the preferred choice for brain tumors, spinal cord tumors, and cancers in the pelvis, including prostate cancer. An MRI with contrast dye is considered the best way to visualize certain tumor types in the brain and spine.
MRI is also commonly used for breast cancer evaluation (sometimes alongside mammography), liver lesions, and musculoskeletal tumors. Because it doesn’t involve radiation, it can be repeated without the cumulative exposure concerns that come with CT. The trade-off is time: an MRI scan typically takes 30 to 60 minutes, and the enclosed scanner can be uncomfortable for some people.
PET Scans: Spotting Active Cancer Cells
PET scans (positron emission tomography) work differently from CT or MRI. Instead of just showing anatomy, they reveal metabolic activity. You receive an injection of a sugar-based radioactive tracer. Cancer cells, which consume sugar faster than normal cells, absorb more of the tracer and light up on the scan.
This makes PET especially powerful for cancer staging, determining whether the disease has spread beyond the original site. In lung cancer, for example, PET/CT identifies tumor spread that standard methods miss in roughly 20% of cases. It can reveal unsuspected disease in lymph nodes that look normal-sized on CT alone. Doctors also use PET to assess whether a tumor is responding to chemotherapy or radiation: if the bright spots dim after treatment, that’s a good sign.
PET is almost always combined with CT in a single PET/CT scanner. The PET component highlights areas of abnormal activity, while the CT provides the anatomical map to pinpoint exactly where those hot spots are.
Mammograms: Screening for Breast Cancer
Mammograms are specialized X-rays of the breast and remain the primary screening tool for breast cancer. Radiologists look for masses, areas of distortion, and tiny calcium deposits called microcalcifications. These calcium specks are significant: 30 to 50% of breast cancers that can’t be felt by hand are detected solely through microcalcifications on a mammogram.
Not all calcifications are dangerous. Benign ones tend to be larger, rounder, and smoother. Suspicious ones are small, irregularly shaped, and often clustered together. Radiologists classify them by shape and distribution. Fine linear branching calcifications carry the highest concern, with about a 78% chance of malignancy. Coarse, unevenly shaped ones sit around 13%. This grading system helps determine whether a biopsy is needed or whether it’s safe to simply monitor with follow-up imaging.
About 10% of mammograms lead to a callback for additional testing. Of those, only about 7% ultimately result in a cancer diagnosis, which means false alarms are common. That’s worth knowing so a callback doesn’t cause unnecessary panic.
Ultrasound: Cyst Versus Solid Mass
Ultrasound uses sound waves to create real-time images. Its most important role in cancer detection is distinguishing fluid-filled cysts (usually harmless) from solid masses (which need further investigation). Sound waves bounce differently off liquid than off solid tissue, giving radiologists a reliable way to tell the two apart without any radiation or contrast dye.
Ultrasound is frequently used to evaluate lumps in the breast, thyroid, and testicles, and to examine the liver and kidneys. It’s also used during biopsies to guide the needle to the right spot in real time. Its limitations are depth and detail: it doesn’t penetrate bone or air-filled organs well, and it’s less useful for cancers deep inside the chest or abdomen.
Bone Scans: Detecting Metastasis to Bone
Bone scans are used primarily to check whether cancer has spread to the skeleton. You receive an injection of a radioactive tracer that naturally gravitates toward areas of active bone remodeling. The tracer gets absorbed into the mineral surface of bone wherever cells are actively building or repairing tissue. Because cancer that has metastasized to bone triggers this kind of rapid remodeling, those areas show up as bright spots.
Bone scans are highly sensitive, meaning they catch most metastatic bone lesions. The downside is that they aren’t specific to cancer. Arthritis, fractures, and infections also cause bone remodeling and can produce similar-looking hot spots. When a bone scan shows something suspicious, doctors typically follow up with CT or MRI to get a clearer picture of what’s happening.
Why Scans Alone Can’t Confirm Cancer
No imaging scan, no matter how advanced, can definitively diagnose cancer on its own. Scans reveal masses, abnormal activity, and suspicious features, but they cannot tell the difference between cancerous cells and noncancerous ones at the cellular level. For most cancers, a biopsy is required. That means removing a small sample of tissue and examining it under a microscope, which is the only way to confirm a diagnosis and determine the specific type of cancer.
Think of imaging as the detection step and biopsy as the confirmation step. A scan might show a suspicious lung nodule, an irregular breast mass, or an unusually active lymph node, but treatment decisions depend on what the cells actually look like under magnification.
What to Expect With Contrast Dye
Many CT and MRI scans use contrast dye to make tumors and blood vessels stand out more clearly. For CT, the contrast is iodine-based and may be injected into a vein or swallowed as a drink. For MRI, the contrast agent is gadolinium-based. Both can cause mild side effects like a warm flushing sensation or a metallic taste.
The main concern with contrast dye is kidney function. People with impaired kidneys face a higher risk of a condition where the dye temporarily worsens kidney performance. This reaction typically shows up within 24 to 72 hours of the scan. That’s why your medical team will often check your kidney function with a blood test before scheduling a contrast-enhanced scan, especially if you have diabetes, are over 60, or have a history of kidney problems.
How Doctors Choose Which Scan to Use
The choice of scan depends on what doctors are looking for. CT is the workhorse for chest, abdominal, and pelvic cancers. MRI is first-line for brain, spinal, and certain pelvic tumors. PET/CT is the gold standard for staging and checking for spread. Mammograms are used specifically for breast screening. Ultrasound is the starting point for evaluating superficial lumps and distinguishing cysts from solid masses. Bone scans are ordered when there’s concern about skeletal metastasis.
In many cases, you’ll undergo more than one type of scan. A CT might find a suspicious mass, a PET/CT might check whether it has spread, and an MRI might provide finer detail of the tumor’s relationship to surrounding tissue. Each scan adds a different piece of information, and together they give your care team a complete picture before treatment planning begins.